Trials / Completed
CompletedNCT05906667
Sharing History Through Active Reminiscence and Photo-imagery - With MCI
Sharing History Through Active Reminiscence and Photo-imagery: A Neighborhood Approach to Increase Physical Activity and Social Engagement
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 55 Years – 95 Years
- Healthy volunteers
- Accepted
Summary
The SHARP-MCI study tests impact of walking and social reminiscence on cognitive function, blood pressure, and weight among healthy Black Americans and those experiencing mild cognitive impairment (MCI).
Detailed description
For 6 months (24 weeks), triads of healthy and MCI Black adults aged 55 and over walk 3x/week (1 mile) in Portland's historically Black neighborhoods. Triads follow GPS-mapped routes accessible via the SHARP walking application on a group tablet device. At three points along each route, GPS-triggered "Memory Markers" (historical images of local Black culture and life from1940-2010) appear on the tablet screen serving as a conversational reminisce prompt as the triad walks. At baseline and 24 weeks, cognitive function is measured via the Montreal Cognitive Assessment (MoCA), and weight and blood pressure are measured. Pre-post health surveys rate activity levels, days feeling downhearted/blue, energy level, and health status. Program evaluation surveys at month 1, 3, 6 assess mood, pace and dose of walking, prompt effectiveness, program readiness, and liklihood to recommend program to others. Focus groups at month 1, 3, 6 evaluate participants' program experience and needed changes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Sharing History through Active Reminiscence and Photo-imagery (SHARP) | Participants engage in neighborhood walks and conversational reminisce three times per week over 24 weeks |
Timeline
- Start date
- 2017-05-24
- Primary completion
- 2018-04-30
- Completion
- 2020-08-30
- First posted
- 2023-06-18
- Last updated
- 2023-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05906667. Inclusion in this directory is not an endorsement.